Correlation Between MediciNova and Unicycive Therapeutics

Can any of the company-specific risk be diversified away by investing in both MediciNova and Unicycive Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MediciNova and Unicycive Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between MediciNova and Unicycive Therapeutics, you can compare the effects of market volatilities on MediciNova and Unicycive Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MediciNova with a short position of Unicycive Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of MediciNova and Unicycive Therapeutics.

Diversification Opportunities for MediciNova and Unicycive Therapeutics

0.62

Correlation Coefficient

MediciNova  Unicycive Therapeutics

Poor diversification

The 3 months correlation between MediciNova and Unicycive is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding MediciNova and Unicycive Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Unicycive Therapeutics and MediciNova is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MediciNova are associated (or correlated) with Unicycive Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Unicycive Therapeutics has no effect on the direction of MediciNova i.e., MediciNova and Unicycive Therapeutics go up and down completely randomly.

Pair Corralation between MediciNova and Unicycive Therapeutics

Given the investment horizon of 90 days MediciNova is expected to generate 4.29 times less return on investment than Unicycive Therapeutics. In addition to that, MediciNova is 1.26 times more volatile than Unicycive Therapeutics. It trades about 0.05 of its total potential returns per unit of risk. Unicycive Therapeutics is currently generating about 0.24 per unit of volatility. If you would invest  36.00  in Unicycive Therapeutics on October 6, 2024 and sell it today you would earn a total of  43.00  from holding Unicycive Therapeutics or generate 119.44% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

MediciNova  vs.  Unicycive Therapeutics

MediciNova

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in MediciNova are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady basic indicators, MediciNova showed solid returns over the last few months and may actually be approaching a breakup point.

Unicycive Therapeutics

Risk-Adjusted Performance

19 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Unicycive Therapeutics are ranked lower than 19 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak fundamental indicators, Unicycive Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with MediciNova and Unicycive Therapeutics

The main advantage of trading using opposite MediciNova and Unicycive Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MediciNova position performs unexpectedly, Unicycive Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Unicycive Therapeutics will offset losses from the drop in Unicycive Therapeutics' long position.

The idea behind MediciNova and Unicycive Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.